Suppr超能文献

经导管主动脉瓣植入术在 90 岁以上患者中的应用:德国主动脉瓣登记研究(GARY)的结果。

Transcatheter aortic valve implantation in nonagenarians: insights from the German Aortic Valve Registry (GARY).

机构信息

Department of Internal Medicine I, St. Johannes Hospital, Johannesstrasse 9-13, 44137, Dortmund, Germany.

Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, University Hospital Ruhr-University Bochum, Bad Oeynhausen, Germany.

出版信息

Clin Res Cardiol. 2020 Sep;109(9):1099-1106. doi: 10.1007/s00392-020-01601-4. Epub 2020 Jan 28.

Abstract

OBJECTIVE

The aim of this study was to compare the outcome of nonagenarians (≥ 90 years) with that of younger (< 90 years) patients undergoing transcatheter aortic valve implantation (TAVI) in current practice.

METHODS

Data are collected from the German Aortic Valve Registry (GARY), which was designed to evaluate current practice in the invasive treatment of patients with aortic valve diseases in Germany. Data were analyzed regarding procedural outcome, 30-day, and 1-year outcomes of nonagenarians in comparison to that of younger patients.

RESULTS

Between 2011 and 2015, 2436/33,051 (7.3%) nonagenarians underwent TAVI and were included in GARY. Nonagenarians were significantly more often male (45.2% vs. 40.0%, p < 0.001), frail (38.7% vs. 34.7%, p < 0.001), and had higher EuroSCORE scores than younger patient group (23.2% vs. 17.0%). Nonagenarians were significantly less often treated via transapical access (16.3% vs. 22.3%, p < 0.001). Procedure was performed significantly less often in general anesthesia (58.2% vs. 60.7%, p = 0.02) in nonagenarians, while necessity of pacemaker implantation was significantly higher in nonagenarians (27.2% vs. 24.8%, p > 0.001). The incidence of other typical postprocedural complications such as severe bleeding events and vascular complications were comparable between groups. However, 30-day (5.2% vs. 3.9%) and 1-year (22.7% vs. 17.7%) mortality rates were significantly higher among nonagenarians and age ≥ 90 years could be identified as an isolated risk factor for mortality.

CONCLUSION

TAVI is a highly standardized procedure that can be performed safely with high procedural success even in very old patients. Although mortality is significantly higher in these patients-most probably due to the intrinsic higher risk profile of the very old patients-the results are still acceptable. To optimize outcome, especially elderly patients seem to profit from a procedure under local anesthesia or conscious sedation, to minimize the rate of postoperative delirium and the length of stay and to facilitate early mobilization.

摘要

目的

本研究旨在比较非 90 岁以上(≥90 岁)患者与年轻患者(<90 岁)行经导管主动脉瓣植入术(TAVI)的治疗效果。

方法

研究数据来源于德国主动脉瓣登记处(GARY),旨在评估德国采用经导管主动脉瓣置换术治疗主动脉瓣疾病的现状。本研究对比了非 90 岁以上患者和年轻患者的围手术期结局、30 天和 1 年的治疗效果。

结果

2011 年至 2015 年期间,共有 2436/33051(7.3%)名非 90 岁以上患者接受了 TAVI 治疗并被纳入 GARY 登记处。非 90 岁以上患者多为男性(45.2%比 40.0%,p<0.001),身体状况更差(38.7%比 34.7%,p<0.001),欧洲心脏手术风险评估系统(EuroSCORE)评分也高于年轻患者(23.2%比 17.0%)。非 90 岁以上患者经心尖途径治疗的比例较低(16.3%比 22.3%,p<0.001)。与年轻患者相比,非 90 岁以上患者较少采用全身麻醉(58.2%比 60.7%,p=0.02),但需要植入起搏器的比例更高(27.2%比 24.8%,p>0.001)。两组严重出血事件和血管并发症等其他典型术后并发症的发生率相似。然而,非 90 岁以上患者的 30 天死亡率(5.2%比 3.9%)和 1 年死亡率(22.7%比 17.7%)更高,年龄≥90 岁可作为独立的死亡危险因素。

结论

TAVI 是一种高度标准化的手术,即使在非常高龄的患者中也能安全进行,且手术成功率较高。尽管这些患者的死亡率明显较高(很可能是由于高龄患者本身的风险较高),但治疗效果仍可接受。为了优化治疗效果,特别是老年患者,采用局部麻醉或镇静治疗可能更有利,可以降低术后谵妄发生率和住院时间,促进早期活动。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验